Dana-Farber’s Kornelia Polyak, MD, PhD, FAACR, is the recipient of the 2023 AACR Distinguished Lectureship…
karnottDecember 13, 2023
A rare but potent genetic mutation that alters a protein in the brain’s immune cells,…
karnottDecember 12, 2023
The world’s first commercial gene-editing treatment is set to start changing the lives of people…
karnottDecember 12, 2023
Two young researchers in McGovern Institute labs, Joseph Itiat and Sam Merrow, are the newest…
karnottDecember 12, 2023
A four-year-old Boston startup is getting $90 million to help develop radioactive molecules that target…
karnottDecember 11, 2023
Vital pulp therapy and root canal therapy (RCT) are the dominant treatment for irreversible pulpitis.…
karnottDecember 11, 2023
Adding an immunotherapy agent to the standard therapy for HER2+ metastatic breast cancer can significantly…
karnottDecember 11, 2023
Each gene in the human genome has two copies. When researchers detect two mutations within…
karnottDecember 8, 2023
Spinal muscular atrophy (SMA) is caused by mutations in SMN1. SMN2 is a paralogous gene…
karnottDecember 7, 2023
